BioHarvest Sciences Inc.
CNVCF
$0.1802
-$0.0066-3.53%
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 55.99% | -19.95% | 64.69% | -60.07% | -28.91% |
| Total Depreciation and Amortization | 11.86% | 10.00% | 45.59% | 39.13% | 67.24% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -118.49% | 27.50% | -1,436.04% | 176.77% | 3.17% |
| Change in Net Operating Assets | 2,738.46% | -170.24% | 251.76% | -349.35% | -92.12% |
| Cash from Operations | 60.17% | -65.78% | 33.88% | -9.54% | -74.81% |
| Capital Expenditure | -57.71% | -13.62% | 3.84% | 25.71% | 44.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -57.71% | -13.62% | 3.84% | 25.71% | 44.86% |
| Total Debt Issued | -59.92% | 109.63% | -- | -- | -- |
| Total Debt Repaid | -13.10% | -7.87% | 19.42% | 19.42% | 8.70% |
| Issuance of Common Stock | -100.00% | -- | -- | -98.00% | -86.32% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -69.15% | 133.96% | 1,334.88% | 4,309.43% | -26.85% |
| Foreign Exchange rate Adjustments | -- | 145.45% | -- | 100.00% | 100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -123.91% | 3,007.69% | 49.63% | 80.11% | -68.01% |
